All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @drkendalstewart on TikTok · 47s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @drkendalstewart's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00And in fact, BPC-157 plus TB-500 is called a wolverine stack.
  2. 0:05You'll find out all the guys at the gym
  3. 0:07are taking wolverine stacks to try to get buff.
  4. 0:11You know what I mean?
  5. 0:12So it's another mechanism to repair your tissues quicker,
  6. 0:15because when you use your tissues,
  7. 0:18it's not the use that actually, you know,
  8. 0:21causes the growth and repair.
  9. 0:22It's the recovery.
  10. 0:24And so what it tends to do is assist with the recovery
  11. 0:28of tissues, and that's why a lot of people are using it.
  12. 0:31We use it quite a bit.
  13. 0:33I take it.
  14. 0:34It can be taken sublingually.
  15. 0:37Works very well, and really is just about telling the body,
  16. 0:41hey, it's time to repair.
  17. 0:42It's not time to stay in your depleted state.

BPC-157 and TB-500 'Wolverine stack': Hype vs. actual evidence

Dr Kendal Stewart

TikTok creator

127.2K viewsWatch on TikTok

Quick answer

BPC-157 and TB-500 are synthetic peptides with mechanistic plausibility for tissue repair based on animal research, but neither has completed peer-reviewed randomized controlled trials in humans for musculoskeletal or athletic recovery indications. BPC-157 is not FDA-approved and has faced compounding restrictions as of 2022, placing patients who use it outside the coverage of standard clinical evidence and regulatory safety frameworks. Sublingual administration of either compound lacks published pharmacokinetic data in humans, making Stewart's delivery method claim an unverified assertion rather than an evidence-based recommendation.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksBPC-157Provider discussion

Evidence signal

Source-backed review

Regulatory reality

BPC-157 access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For BPC-157 and TB-500 'Wolverine stack': Hype vs. actual evidence, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

BPC-157 is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this bpc-157 video claims cluster

Best for searchers trying to separate BPC-157 research signals from overconfident recovery claims.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "BPC-157 and TB-500 'Wolverine stack': Hype vs. actual evidence" from Dr Kendal Stewart. We read the clip as a Peptide social video fact-checks claim about BPC-157, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: BPC-157 and TB-500 are synthetic peptides with mechanistic plausibility for tissue repair based on animal research, but neither has completed peer-reviewed randomized controlled trials in humans for musculoskeletal or athletic recovery indications.

The reason this review is not generic is the source wording and the canonical claim label "peptides bpc 157 tb500 is known as the wolverine stack for a reason i." In this clip, the useful excerpt is: "And in fact, BPC-157 plus TB-500 is called a wolverine stack." That wording changes the review because it points to BPC-157 safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against Multifunctionality and Possible Medical Application of the BPC 157 Peptide (2025), Gastric pentadecapeptide BPC 157 and its role in accelerating musculoskeletal soft tissue healing (2019), and Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review (2025), plus the creator's own wording. BPC-157 still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

The FDA moved in 2022 to restrict BPC-157 as a compounded drug ingredient, citing lack of clinical evidence and safety data, which places users in an unregulated risk environment.
People who land here are usually comparing the BPC-157 claim with [object Object].
The strongest next step is to compare the claim with FormBlends' BPC-157 guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

BPC-157 and TB-500 are synthetic peptides with mechanistic plausibility for tissue repair based on animal research, but neither has completed peer-reviewed randomized controlled trials in humans for musculoskeletal or athletic recovery indications.

FormBlends verdict

BPC-157 safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the BPC-157 guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • BPC-157 and TB-500 are synthetic peptides with mechanistic plausibility for tissue repair based on animal research, but neither has completed peer-reviewed randomized controlled trials in humans for musculoskeletal or athletic recovery indications. BPC-157 is not FDA-approved and has faced compounding restrictions as of 2022, placing patients who use it outside the coverage of standard clinical evidence and regulatory safety frameworks. Sublingual administration of either compound lacks published pharmacokinetic data in humans, making Stewart's delivery method claim an unverified assertion rather than an evidence-based recommendation.
  • No completed human RCTs exist for BPC-157 or TB-500 in athletic or musculoskeletal recovery contexts as of 2024, meaning efficacy claims rest entirely on animal data and anecdote.
  • The FDA moved in 2022 to restrict BPC-157 as a compounded drug ingredient, citing lack of clinical evidence and safety data, which places users in an unregulated risk environment.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • BPC-157 decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the BPC-157 guide, cost path, safety notes, and provider review before acting.

Review BPC-157

What You'll Learn

  • No completed human RCTs exist for BPC-157 or TB-500 in athletic or musculoskeletal recovery contexts as of 2024, meaning efficacy claims rest entirely on animal data and anecdote.
  • The FDA moved in 2022 to restrict BPC-157 as a compounded drug ingredient, citing lack of clinical evidence and safety data, which places users in an unregulated risk environment.
  • Sikiric et al. (2018, Current Pharmaceutical Design) documents BPC-157 effects on tendon and gut healing in rodents, but rodent pharmacology does not automatically translate to human outcomes.
  • Goldstein et al. (2012, Annals of the New York Academy of Sciences) found TB-500 promising in corneal and cardiac wound healing, not in gym recovery or athletic performance contexts.
  • Sublingual peptide delivery has no published human pharmacokinetic studies for either compound; the claim that it 'works very well' this way is not evidence-based.
  • The supercompensation principle Stewart references is legitimate exercise physiology, but attributing this mechanism specifically to an unstudied peptide combination is an unsupported leap.
  • Gym culture adoption of a compound is a social trend, not clinical evidence. Peptide stacks sourced outside regulated pharmacy channels carry unknown purity and dosing risks.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @drkendalstewart actually say?

The claim is straightforward: combining BPC-157 and TB-500, nicknamed the "Wolverine stack," helps the body repair tissues faster by supporting recovery rather than directly causing growth. Stewart says he takes it himself, that it can be taken sublingually, and frames it as essentially signaling the body to "repair" instead of staying in a "depleted state." He also drops that "all the guys at the gym" are using it to "get buff," which is a different claim than healing, and a distinction worth keeping straight.

That framing matters. Recovery-driven repair is actually the correct physiological framing for how training adaptations work. But saying a peptide stack tells your body "hey, it's time to repair" is a loose mechanistic shorthand that glosses over significant gaps in human evidence.

Does the science back this up?

For BPC-157, the rodent data is genuinely interesting. Less so for humans. For TB-500, the picture is even murkier. These aren't interchangeable with clinical proof of efficacy in people.

BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide derived from a protein found in gastric juice. Animal studies show accelerated healing in tendons, muscles, and gut tissue. Sikiric et al. (2018, Current Pharmaceutical Design) documented consistent pro-angiogenic and cytoprotective effects in rodent models. The problem: no completed, peer-reviewed randomized controlled trials in humans exist for musculoskeletal applications. The FDA has not approved BPC-157 for any indication, and in 2022 the agency moved to restrict its use in compounded preparations.

TB-500, or Thymosin Beta-4, has some human data, but almost entirely in wound healing contexts, not athletic recovery. Goldstein et al. (2012, Annals of the New York Academy of Sciences) reviewed TB-500's role in tissue repair and found promising results in corneal and cardiac wound healing, again, not gym recovery. The "Wolverine stack" branding combines two compounds with very different evidence bases and assumes synergy that hasn't been studied together in humans at all.

What did they get wrong (or right)?

Stewart gets the physiology of recovery directionally right. The idea that "it's not the use that causes growth, it's the recovery" is a fair lay summary of supercompensation theory, the well-established principle that adaptation happens during rest, not during the training stimulus itself. Credit where it's due.

Where it gets shaky: the sublingual delivery claim. BPC-157 is a peptide. Peptides are chains of amino acids. When you put a peptide under your tongue, the mucosal absorption question is genuinely complicated. Most peptide researchers studying BPC-157 use injectable or oral routes in animal models. There is no published pharmacokinetic data on sublingual BPC-157 absorption in humans. Saying it "works very well" sublingually is an assertion, not a finding.

The "all the guys at the gym are taking it" framing also does real harm. Widespread anecdotal use is not evidence of safety or efficacy. It's a social proof argument dressed up as clinical context. That framing can push viewers toward unregulated, variable-quality peptide products from sources with zero quality controls.

What should you actually know?

The honest version of this topic is more complicated than a 60-second TikTok allows. BPC-157 and TB-500 are being studied, and there are legitimate reasons researchers find them interesting. But "interesting in rodent models" and "proven to work in humans" are separated by a significant evidentiary gap that this video doesn't acknowledge.

Both compounds exist in a regulatory gray zone. In the US, BPC-157 is not FDA-approved and has faced increasing scrutiny as a compounded drug ingredient. Patients obtaining these peptides from telehealth platforms or wellness clinics are participating in what is essentially off-label use of compounds without completed human trials. That doesn't automatically make them dangerous, but it means the risk-benefit calculation is genuinely unknown, not just "probably fine."

If you're considering peptide therapy, the conversation should happen with a licensed provider who can review your health history, not because a TikTok told you the gym guys are all doing it. Stewart is a physician, and that carries weight, but the video presents gym culture adoption as supporting evidence, which it isn't.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Dr Kendal Stewart · TikTok creator

127.2K views on this video

BPC-157 + TB500 is known as the “Wolverine stack” for a reason. It supports tissue recovery, not just growth. Recovery is what drives repair, making this stack popular for healing and performance. #InjuryHealing #RecoveryStack #PerformanceBoost

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about no completed human rcts exist for bpc-157?

No completed human RCTs exist for BPC-157 or TB-500 in athletic or musculoskeletal recovery contexts as of 2024, meaning efficacy claims rest entirely on animal data and anecdote.

What does the video say about the fda moved in 2022 to restrict bpc-157 as a?

The FDA moved in 2022 to restrict BPC-157 as a compounded drug ingredient, citing lack of clinical evidence and safety data, which places users in an unregulated risk environment.

What does the video say about sikiric et al. (2018, current pharmaceutical design) documents bpc-157 effects?

Sikiric et al. (2018, Current Pharmaceutical Design) documents BPC-157 effects on tendon and gut healing in rodents, but rodent pharmacology does not automatically translate to human outcomes.

What does the video say about goldstein et al. (2012, annals of the new york academy?

Goldstein et al. (2012, Annals of the New York Academy of Sciences) found TB-500 promising in corneal and cardiac wound healing, not in gym recovery or athletic performance contexts.

What does the video say about sublingual peptide delivery has no published human pharmacokinetic studies for?

Sublingual peptide delivery has no published human pharmacokinetic studies for either compound; the claim that it 'works very well' this way is not evidence-based.

What does the video say about the supercompensation principle stewart references?

The supercompensation principle Stewart references is legitimate exercise physiology, but attributing this mechanism specifically to an unstudied peptide combination is an unsupported leap.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Dr Kendal Stewart, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.